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Editorial Comment
Ventricular Premature Complexes
as Villains: Still an Important
Part of the Problem*
STEPHEN SCHEIDT, MD, FACC
New York, New York
Ventricularectopic activity has long been recognizedto have
an adverse effect on prognosis after acute myocardial in-
farction. The pioneering studies that initially made car-
diologists aware of this relation were relatively unsophis-
ticated by today's standards: Ruberman et al. (I), studying
I ,739 male survivors of myocardial infarction in the Health
Insurance Plan, used I hour of single lead office electro-
cardiographic (ECG) monitoring on tape; Moss et al. (2-4).
in a series of reports from Rochester, used a 6 hour daytime
ambulatory recording;and Kotleret al. (5), studying patients
2:3 months after infarction, used 10 to 12 hour ambulatory
ECG recordings every 8 months. In each case, a number
of other clinical variables were considered and various sim-
ple stratifications for risk of death or sudden death were
proposed.
Several authors (3,6-8) raised the possibility that ven-
tricular ectopic activity might be related to a more basic
problem, such as myocardial damage or dysfunction, when
they showed that ectopic activity was strongly correlated
with the extent of left ventricular dysfunction, presumably
related to the total extent of myocardial damage.
Recent studies in ventricular ectopic activity. A1-
though few have doubted that ventricular ectopic activity is
a significant adverse prognostic factor, some controversy
was generated in the late 1970s and early 1980s in two
areas: First. is ventricular ectopic activity an independent
adverse factor, or merely a marker for extensive myocardial
damage? Second, are some types of ventricular ectopic ac-
tivity more dangerous than others? This question is usually
refinedto suggest that" simple" ventricularectopic activity.
for example, infrequent single ventricular premature beats
alone, might not be important, whereas "complex" ectopic
activity (frequent, multifocal, pairs, or runs of ventricular
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premature beats, or ventricular tachycardia) would be im-
portant.
More recent investigations examined multiple clinical
variables in addition to ambulatory ECG monitoring and
objective measurement of left ventricular function in larger
groups of patients at a single institution (9) and in multi-
center studies encompassing 766 patients at nine institutions
(The Multicenter Post-Infarction Research Group) (10) and
533 patients at five institutions (The Multicenter Investi-
gation of the Limitation of Infarct Size [MIllS]) (II). These
studies indicate that ventricular ectopic activity. although
strongly correlated with left ventricular dysfunction, is an
independent risk factor for death after myocardial infarction.
Further, both simple ventricular premature beats and com-
plex ventricular arrhythmias are risk factors; it was sug-
gested in one study that even as few as > I and particularly
2:3 ventricular premature beats/h or a single ventricular
premature pair in a 24 hour period markedly increased the
risk over a follow-up period of several years (10).
The present study. In this issue of the Journal, Kostis
et al. (12) present the largest body of data yet reported to
confirm and extend these presumptions. As part of the Beta-
Blocker Heart Attack Trial (BHAT), 3,290 patients had 24
hourambulatory ECG performed before randomization. There
were large numbers of subjects with ventricular ectopic ac-
tivity: 84% had at least I ventricular premature beat/24 h,
33% had multiform and about 20% had repetitive ventricular
premature beats. Not unexpectedly, ventricular ectopic ac-
tivity was related to factors suggesting increasing myo-
cardial dysfunction, including myocardial infarction before
the current infarct, increasing age, congestive heart failure,
recent angina and others. (Ventricular ectopic activity was
not related to serum potassium, which is sometimes sus-
pected as linking diuretic use to possible adverse effects of
antihypertensive therapy, nor was there any relation of ven-
tricular ectopic activity to the site of infarction [anterior,
inferior, Q wave versus non-Q wave].) Also as expected,
Kostis et al. (12) confirmed that ventricular ectopic activity
had a significant relation to total mortality in the 1,640
BHAT patients randomized to the placebo group over an
average 25 month follow-up period.
Definitions of grade of ventricular arrhythmia. Def-
initions of ventricular ectopic activity have differed, but in
general most authorities agree that a limited numberof single
ventricular premature beats (' 'limited" often definedas < 10
to 30/h) is less dangerous than frequent, multiformed or
paired ventricular premature beats, or ventricular tachycar-
dia. The study of Kostiset al. (12) is the first with a sufficient
number of patients to examine the relative importance of
different definitions of ventricular ectopic activity. In the
BHAT, all the cited types of complex ventricular ectopic
activity, when present, had substantial but relatively equal
0735-1 097/87/H 50
244 SCHEIDT
EDITORIAL COMMENT
lACC Vol. 10, NO.2
August 1987:243-5
influence on mortality; risk did increase with increasing
numbers of ventricular premature beats, pairs or ventricular
tachycardia episodes per hour. The implicit gradient of risk
in the well known Lown arrhythmia classification was not
seen in this as in previous studies (13); that is, Lown grade
2 (multiple ventricular premature beats > IImin or 30/h)
seems quite as dangerous as grade 3 (multifocal ventricular
premature beats), or grade 4 (repetitive premature beats or
ventricular tachycardia) at least in the 2 years after acute
myocardial infarction in the BHAT. Lown grade 5 (R on T
ventricular premature beats) was apparently not examined
in the BHAT study of Kostis et al.
Factors affecting prognostic importance of ventricu-
lar arrhythmias. The influence of ventricular ectopic ac-
tivity on mortality in the BHAT was independent of other
variables reflecting left ventricular impairment (congestive
heart failure, prior myocardial infarction, lactic dehydro-
genase levels during hospitalization), traditional atheroscle-
rotic risk factors and other factors including ST segment
depression on the rest ECG. These findings confirm those
of several other large studies. Thus, for both prognostication
and treatment after acute myocardial infarction, it is clear
that physicians need to take into account both left ventricular
function and ventricular ectopic activity (and likely other
factors such as extent of jeopardized myocardium).
Several additional factors may confound matters. One is
the time of evaluation. In another report from the BHAT
(14), ventricular ectopic activity increased substantially from
the initial 24 hour ambulatory ECG recording obtained 5 to
21 days after acute infarction to the follow-up recording
some 6 weeks later. The significance of evaluation time was
confirmed by a recent report (15) of serial electrophysiologic
studies at 5 and 24 days after infarction demonstrating much
higher inducibility of sustained ventricular arrhythmia on
day 24 (9 of 18 patients) as compared with that on day 5
(2 of 18). Future studies on prevalence of ventricular ar-
rhythmia or treatment thereof will need to carefully specify
the times of evaluation. Some past investigators reporting
changes in arrhythmia attributed to therapy may have been
misled by the natural history of ventricular arrhythmia, which
increases substantially in the first few weeks after hospital
discharge (at a time when the patients' condition seems
improved by most clinical criteria) and then presumably
decreases, but with an as yet poorly understood time course.
The prognostic importance of reversible ischemia is also
unclear. Although one would logically expect more ven-
tricular ectopic activity in patients with ischemic as well as
infarcted myocardium, most reports studying provoked isch-
emia (for example, by postinfarction stress testing) have
included too few study subjects to define with certainty the
relative prognostic importance of ventricular ectopic activ-
ity, left ventricular dysfunction due to infarction and ad-
ditional reversible ischemia.
Therapeutic implications. Given all these interrela-
tions, what are the implications for current treatment after
acute myocardial infarction? First, the importance of ven-
tricular ectopic activity as an independent prognostic factor
is affirmed, and with it the usefulness of 24 hour ambulatory
ECG monitoring in both low and high risk groups. In the
BHAT study of Kostis et al. (12), complex ventricular ar-
rhythmia increased the total death rate in high risk patients
by 30 to 40%, but increased the risk by nearly 400% in the
low risk subgroup-those without prior myocardial infarc-
tion, ST depression or cardiomegaly. For now, this infor-
mation is most useful in patients without complex ventricular
arrhythmia: they can be reassured and encouraged to rapidly
return to normal activities. For those with complex ventric-
ular ectopic activity, risk stratification according to addi-
tional variables is all the more important. In the BHAT
study of Kostis et al., patients with anyone of three simply
evaluated clinical factors (I) prior myocardial infarction, 2)
ST depression on rest ECG, or 3) chest X-ray cardiothoracic
ratio >0.50, plus any complex ventricular ectopic activity
[ventricular premature beats> 10/h, paired or multiform
ventricular premature beats or ventricular tachycardia)) had
a total mortality rate of 15.8% within a mean follow-up
time of 25 months. Those with two of these nonarrhythmia
risk factors plus complex ventricular ectopic activity had a
25 month mortality rate of 21 .1%, whereas infarct survivors
with all three nonarrhythmic risk factors plus complex ven-
tricular ectopic activity had a mortality rate of 41.2% over
25 months.
In the Multicenter Post-Infarction Research Group (10),
2 year mortality rates were similarly high, about 40% in
subjects with radionuclide left ventricular ejection fraction
<30% plus repetitive ventricular premature complexes,
whereas in the MILlS (11), the mortality rate at 18 months
was also 40% in those with ejection fraction <40% and
~ 10 ventricular premature complexes/h (most of whom also
had repetitive ventricular premature complexes). These me-
dium-term mortality figures are so high that some interven-
tion needs to be considered, but unfortunately we do not
yet know which one: beta-blockers (certainly, if there are
no contraindications); other antiarrhythmic drugs (on the
basis of studies in progress with no current data to support
this course); or coronary angioplasty or bypass surgery (not
shown to improve 5 year survival in unselected asympto-
matic postinfarction patients [randomized as group C of the
Coronary Artery Surgery Study (16)] but very possibly use-
ful in postinfarction patients with substantial jeopardized
myocardium as documented by exercise testing).
In an age offiscal restraint, it is uncomfortable to rec-
ommend more routine testing for the > 1 million patients
with myocardial infarction treated yearly in the United States,
but it is hard to escape the conclusion that risk stratification
is most accurate with evaluation of ventricular function plus
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detection of ventricular ectopic activity (and perhaps as-
sessment of the extent of jeopardized myocardium). The
challenge for the next few years will be to accomplish this
stratification most cost-effectively. For example, would a
hand-held nuclear probe used to assess left ventricularejec-
tion fraction at rest and during exercise, together with a I
or 2 hour telemetered and automated ECG evaluation for
ventricular ectopic activity, give most of the requisite data
and be obtainable cheaply enough-perhaps at a cost of
$100 to $150 per patient? Or would exercise two-dimen-
sional echocardiography for assessmentof ventricular func-
tion and jeopardized myocardium plus a few hours of in-
ternally microprocessor-evaluated ECG monitoring for
ventricular arrhythmia be more useful?
Finally, therapeutic approaches need to be validated for
various subgroups. Because the majority of deaths in the
first year or 2 after acute myocardial infarction are sudden
and presumably arrhythmic, it is likely that evaluation of
baseline ventricular ectopic activity and change with treat-
ment will become increasingly important. The BHAT study
of Kostis et al. (12) does provide solid baseline data on the
prevalence and prognostic implications of various types of
ventricular arrhythmia, including sensitivity and specificity
for prediction of mortality for various definitions of ven-
tricular arrhythmia. Whether anti-ischemic measures, anti-
arrhythmic therapy, or treatmentdirected at ventricular dys-
function will be most useful in reducing mortality remains
to be determined, but it is likely that consideration of effects
of any treatment on some measurement of ventricular ec-
topic activity will be essential.
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